Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1962 1
1965 1
1970 1
1972 3
1973 2
1974 1
1975 3
1976 6
1977 8
1978 5
1979 15
1980 11
1981 10
1982 13
1983 18
1984 17
1985 25
1986 21
1987 26
1988 17
1989 20
1990 25
1991 34
1992 43
1993 39
1994 35
1995 51
1996 42
1997 42
1998 59
1999 50
2000 58
2001 69
2002 92
2003 117
2004 148
2005 209
2006 205
2007 226
2008 282
2009 284
2010 410
2011 453
2012 534
2013 639
2014 706
2015 824
2016 838
2017 919
2018 1056
2019 1221
2020 1561
2021 1804
2022 2295
2023 2208
2024 2491
2025 1729
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19,741 results

Results by year

Filters applied: . Clear all
Page 1
Deep insight into cytokine storm: from pathogenesis to treatment.
Nie J, Zhou L, Tian W, Liu X, Yang L, Yang X, Zhang Y, Wei S, Wang DW, Wei J. Nie J, et al. Among authors: wei j. Signal Transduct Target Ther. 2025 Apr 16;10(1):112. doi: 10.1038/s41392-025-02178-y. Signal Transduct Target Ther. 2025. PMID: 40234407 Free PMC article. Review.
Jing Wei.
Wei J. Wei J. Angew Chem Int Ed Engl. 2025 Jun 23:e202512750. doi: 10.1002/anie.202512750. Online ahead of print. Angew Chem Int Ed Engl. 2025. PMID: 40545955
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial.
Qi C, Liu C, Peng Z, Zhang Y, Wei J, Qiu W, Zhang X, Pan H, Niu Z, Qiu M, Qin Y, Fang W, Ye F, Li N, Liu T, Liu A, Zhang X, Hu C, Zhang J, Cui J, Lin X, Wang S, Zhang J, Lin T, Qu X, Yuan X, Gong J, Li J, Gao W, Gai L, Wang Y, Yuan D, Li Z, Shen L. Qi C, et al. Among authors: wei j. Lancet. 2025 Jun 7;405(10494):2049-2060. doi: 10.1016/S0140-6736(25)00860-8. Epub 2025 May 31. Lancet. 2025. PMID: 40460847 Clinical Trial.
NAION risk with semaglutide: what we know so far.
Hsu AY, Wang YH, Lin CJ, Hsia NY, Shao YC, Chiang CC, Chen HS, Tsai YY, Wei JC. Hsu AY, et al. Among authors: wei jc. Eye (Lond). 2025 Jun;39(9):1655-1656. doi: 10.1038/s41433-025-03833-y. Epub 2025 May 7. Eye (Lond). 2025. PMID: 40335680 No abstract available.
Circular RNA-mediated inverse prime editing in human cells.
Liang R, Wang S, Cai Y, Li Z, Li KM, Wei J, Sun C, Zhu H, Chen K, Gao C. Liang R, et al. Among authors: wei j. Nat Commun. 2025 May 31;16(1):5057. doi: 10.1038/s41467-025-59120-7. Nat Commun. 2025. PMID: 40447589 Free PMC article.
The intersection of influenza infection and autoimmunity.
Xie S, Wei J, Wang X. Xie S, et al. Among authors: wei j. Front Immunol. 2025 Apr 3;16:1558386. doi: 10.3389/fimmu.2025.1558386. eCollection 2025. Front Immunol. 2025. PMID: 40248710 Free PMC article. Review.
Natural anti-cancer products: insights from herbal medicine.
Cui D, Zhang C, Zhang L, Zheng J, Wang J, He L, Jin H, Kang Q, Zhang Y, Li N, Sun Z, Zheng W, Wei J, Zhang S, Feng Y, Tan W, Zhong Z. Cui D, et al. Among authors: wei j. Chin Med. 2025 Jun 9;20(1):82. doi: 10.1186/s13020-025-01124-y. Chin Med. 2025. PMID: 40490812 Free PMC article. Review.
19,741 results
You have reached the last available page of results. Please see the User Guide for more information.